MIRA Pharmaceuticals Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: MIRA Pharmaceuticals Inc.
Former names: Mira1a Therapeutics, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Florida
Headquarters city: Miami
Headquarters state / province: Florida
Headquarters country: United States
Ticker symbol: MIRA
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001904286
EIN: 85-3354547

Board of directors

Follow this board

Bradley Kroenig · Director
Since 2023
Brian Frederick Daly · Director
Since 2023
Christopher C. Chapman Jr. · Director · Executive Chairman
Since 2023
Christos Nicholoudis · Director
Since 2023
David C. Vorhoff · Director
Since 2023
Denil Nanji Shekhat · Director
Since 2024
Edward Clouston MacPherson · Director
Since 2024
Erez Aminov · Director · Chief Executive Officer
Since 2023
Giudice Matthew Paul Del · Director
Since 2024
Hugh McColl III · Director
Since 2023
Matthew Pratt Whalen · Director
Since 2024
Michael Allen Jerman · Director
Since 2023
Talhia Tuck · Director
Since 2023

Chief executives

Erez Aminov · CEO and Director

Since August 2023

Director election results

Annual meeting of September 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

11 of this board's directors also sit on 5 other boards. 3 are in the same sector.

Shared director Other board Same sector

Telomir Pharmaceuticals Inc. Same sector
via Bradley Kroenig, Christopher C. Chapman Jr., Christos Nicholoudis, Edward Clouston MacPherson, Erez Aminov, Giudice Matthew Paul Del, Hugh McColl III, Matthew Pratt Whalen, Michael Allen Jerman and Talhia Tuck
Alaunos Therapeutics Inc. Same sector
via Michael Allen Jerman
Q/C Technologies Inc. Same sector
via Christopher C. Chapman Jr.
RRE Ventures Acquisition Corp.
via Brian Frederick Daly
Westrock Coffee Company
via Hugh McColl III

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Oct 16, 2025	Erez Aminov Director, Officer (CEO and Chairman)	Option exercise	+234,595	$1.16	$272,130
Oct 16, 2025	Erez Aminov Director, Officer (CEO and Chairman)	Option exercise	+379,000	$0.84	$318,360
Oct 16, 2025	Erez Aminov Director, Officer (CEO and Chairman)	Open-market sale	−613,595	$2.11	$1,294,685
Oct 1, 2025	Denil Nanji Shekhat Director	Grant or award	+22,378	$1.35	$30,210
Oct 1, 2025	Erez Aminov Director, Officer (Chief Executive Officer)	Grant or award	+2,685,456	—	—
Aug 29, 2025	Erez Aminov Director, Officer (Chief Executive Officer)	Grant or award	+62,500	$1.37	$85,625
Mar 26, 2025	Erez Aminov Director, Officer (CEO and Chairman)	Grant or award	+62,500	$1.45	$90,625
Mar 26, 2025	Erez Aminov Director, Officer (CEO and Chairman)	Grant or award	+62,500	$1.45	$90,625
Nov 20, 2024	Erez Aminov Director, Officer (Chief Executive Officer)	Open-market sale	−44,590	$1.27	$56,629
Nov 19, 2024	Erez Aminov Director, Officer (Chief Executive Officer)	Open-market sale	−55,410	$1.39	$77,020
Aug 28, 2024	McNulty Brian Patrick 10% owner	Open-market sale	−200,000	$1.96	$392,000
May 21, 2024	Erez Aminov Director, Officer (Chief Executive Officer)	Open-market purchase	+2,000	$1.00	$2,000
May 21, 2024	Erez Aminov Director, Officer (Chief Executive Officer)	Open-market purchase	+1,000	$1.03	$1,030
May 21, 2024	Erez Aminov Director, Officer (Chief Executive Officer)	Open-market purchase	+500	$1.02	$510
May 21, 2024	Erez Aminov Director, Officer (Chief Executive Officer)	Open-market purchase	+2,000	$0.84	$1,680

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about MIRA Pharmaceuticals Inc.

Who is the CEO of MIRA Pharmaceuticals Inc.?

Erez Aminov has been MIRA Pharmaceuticals Inc.'s CEO and Director since August 2023.

How many directors are on MIRA Pharmaceuticals Inc.'s board?

MIRA Pharmaceuticals Inc.'s board has 13 directors: Bradley Kroenig, Brian Frederick Daly, Christopher C. Chapman Jr., Christos Nicholoudis, David C. Vorhoff, Denil Nanji Shekhat, Edward Clouston MacPherson, Erez Aminov, Giudice Matthew Paul Del, Hugh McColl III and 3 others.

How is MIRA Pharmaceuticals Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="mira-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.